PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5538.32M
Enterprise Value 3383.3M
Trailing P/E N/A
Forward P/E 1-23.78
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)39.43
Price/Book (mrq)7.64
Enterprise Value/Revenue 328.07
Enterprise Value/EBITDA 6-7.50

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-382.65%

Management Effectiveness

Return on Assets (ttm)-20.86%
Return on Equity (ttm)-67.86%

Income Statement

Revenue (ttm)13.65M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)40.30%
Gross Profit (ttm)11.7M
EBITDA -51.08M
Net Income Avi to Common (ttm)-46.61M
Diluted EPS (ttm)-0.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)87.49M
Total Cash Per Share (mrq)1.16
Total Debt (mrq)47.64M
Total Debt/Equity (mrq)75.83
Current Ratio (mrq)6.34
Book Value Per Share (mrq)0.84

Cash Flow Statement

Operating Cash Flow (ttm)-53.45M
Levered Free Cash Flow (ttm)-34.7M

Trading Information

Stock Price History

Beta 2.94
52-Week Change 3-13.67%
S&P500 52-Week Change 315.79%
52 Week High 39.42
52 Week Low 35.01
50-Day Moving Average 37.72
200-Day Moving Average 37.76

Share Statistics

Avg Vol (3 month) 31.6M
Avg Vol (10 day) 32.49M
Shares Outstanding 583.85M
Float 75.15M
% Held by Insiders 10.52%
% Held by Institutions 174.41%
Shares Short (Aug 31, 2018) 411.2M
Short Ratio (Aug 31, 2018) 45.43
Short % of Float (Aug 31, 2018) 421.39%
Short % of Shares Outstanding (Aug 31, 2018) 413.26%
Shares Short (prior month Jul 31, 2018) 412.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A